Genekam filed EU antitrust complaint against Twitter
Genekam has developed
ultrasensitive Magnetic beads ELISA for SARS CoV-2
Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.